Laboratório Central de Saúde Pública, Secretaria de Saúde do Estado do Rio Grande do Sul-LACEN/SES-RS, Porto Alegre, Rio Grande do Sul, Brazil.
Departamento de Ciências Básicas da Saúde, Laboratório de Biologia Molecular, Universidade Federal de Ciências da Saúde de Porto Alegre-UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil.
J Med Virol. 2019 Aug;91(8):1423-1431. doi: 10.1002/jmv.25459. Epub 2019 Mar 28.
Human parainfluenza virus (hPIV) is an important pathogen in respiratory infections, however the health burden of hPIV is underestimated. This study describes the infections by hPIV1-3 in Rio Grande do Sul, Brazil, from 1990 to 2017, providing data of the frequency and seasonality of cases and associated clinical symptoms.
Nasopharyngeal samples of patients with respiratory infection were collected, clinical data were analyzed, and immunofluorescence was used to detect hPIV.
Respiratory viruses were detected in 33.63% of respiratory infections. In a total of 11 606 cases of viral respiratory infection, 781 were positive for hPIV; hPIV prevalence ranged from 2.14% to 27% of viral respiratory infections. hPIV1 circulates mainly during fall; hPIV3 circulation, in turn, starts in fall and peaks during spring; and cases of hPIV2 are reported along the year, with peaks in fall and early spring. The most affected age group was children, with hPIV prevalence of 74.23% in patients for less than 1 year. A higher proportion of girls were infected than boys, however, no difference by sex was observed considering all age groups. The most frequent type was hPIV3, especially in hospitalized patients. Both hPIV1 and 3 were associated with dyspnea, while hPIV2 caused mild symptoms mainly in nonhospitalized patients. Nineteen fatalities occurred, 89.5% of them associated with risk factors (prematurity; chronic diseases; age, <1 or >60 years).
hPIV causes a high number of respiratory infections, leading to hospitalization especially in children; epidemiological and surveillance studies are important for the control and management of respiratory infections.
人类副流感病毒(hPIV)是呼吸道感染的重要病原体,但 hPIV 的健康负担被低估了。本研究描述了 1990 年至 2017 年巴西南里奥格兰德州 hPIV1-3 的感染情况,提供了病例的频率和季节性以及相关临床症状的数据。
收集呼吸道感染患者的鼻咽拭子,分析临床数据,并使用免疫荧光法检测 hPIV。
呼吸道病毒在 33.63%的呼吸道感染中被检测到。在总共 11606 例病毒性呼吸道感染中,781 例 hPIV 阳性;hPIV 阳性率在病毒性呼吸道感染中占 2.14%至 27%。hPIV1 主要在秋季流行;hPIV3 的流行则始于秋季,在春季达到高峰;hPIV2 的病例则全年报告,秋季和早春达到高峰。受影响最严重的年龄组是儿童,1 岁以下儿童 hPIV 阳性率为 74.23%。感染女孩的比例高于男孩,但在所有年龄组中,性别差异无统计学意义。最常见的类型是 hPIV3,尤其是住院患者。hPIV1 和 3 都与呼吸困难有关,而 hPIV2 主要引起非住院患者的轻度症状。发生了 19 例死亡,其中 89.5%与危险因素(早产;慢性疾病;年龄<1 岁或>60 岁)有关。
hPIV 导致大量呼吸道感染,特别是儿童住院率较高;流行病学和监测研究对于呼吸道感染的控制和管理非常重要。